For instance, the CCR7/DUSP1 signaling axis has been shown to regulate the growth of HNSCC by modulating TGF-β1 secretion in inflammatory cancer-associated fibroblasts, highlighting a critical pathway that could influence therapeutic outcomes in HNSC33. This evidence concerns the gene CCR7 and head and neck squamous cell carcinoma.